Sequent Scientific Ltd., headquartered in India, is a prominent player in the pharmaceutical and biotechnology sectors. Founded in 2006, the company has established itself as a leader in the development and manufacturing of complex generics, particularly in the areas of injectable and oral dosage forms. With a strong operational presence across various regions, Sequent Scientific has achieved significant milestones, including multiple regulatory approvals from global health authorities. The company’s core offerings include a diverse range of pharmaceutical products, with a unique focus on high-quality, cost-effective solutions that cater to the evolving needs of healthcare providers. Sequent Scientific is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the global pharmaceutical landscape. Its notable achievements underscore its dedication to advancing healthcare through reliable and accessible medicines.
How does Sequent Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sequent Scientific's score of 26 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Sequent Scientific reported significant carbon emissions, with total Scope 1 emissions at approximately 9,464,300 kg CO2e and Scope 2 emissions at about 15,137,920 kg CO2e in India. The company's global emissions for the same year included approximately 17,359,720 kg CO2e for Scope 1 and about 13,459,920 kg CO2e for Scope 2. In 2022, Sequent's emissions were notably higher, with Scope 1 emissions reaching around 7,125,210 kg CO2e and Scope 2 emissions at approximately 16,552,140 kg CO2e in India. The global figures for 2022 showed Scope 1 emissions at about 7,125,210 kg CO2e and Scope 2 emissions at around 16,552,140 kg CO2e, while Scope 3 emissions were reported at approximately 5,088,663 kg CO2e. Looking ahead, Sequent Scientific has not publicly committed to specific reduction targets or initiatives, as there are no documented reduction targets or climate pledges available. The company continues to monitor its emissions and may implement strategies to address its carbon footprint in alignment with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | 4,508,663 | 0,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 5,297,974 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 6,000,000 | 0,000,000 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sequent Scientific is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.